Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate if Hydroxocobalamin may be a new and possibly superior treatment for
refractory vasoplegic syndrome during liver transplant surgery.